Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.65% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INST
1451
DELISTED
Instructure Holdings, Inc.
INST
| $4.01M | 0.01% |
171,400
-96,100
| -36% | -$2.05M |
|
1452
Akebia Therapeutics
AKBA
$241M
| $3.99M | 0.01% |
3,914,800
+262,700
| +7% | +$325K |
|
1453
Rackspace Technology
RXT
$1.1B
| $3.99M | 0.01% |
1,339,200
+256,900
| +24% | +$515K |
|
1454
WaFd
WAFD
$2.81B
| $3.99M | 0.01% |
139,530
+27,100
| +24% | +$750K |
|
|
AUTL
1455
Autolus Therapeutics
AUTL
$591M
| $3.98M | 0.01% |
1,145,056
+821,156
| +254% | +$3.54M |
|
1456
Viant Technology
DSP
$274M
| $3.98M | 0.01% |
403,300
-21,900
| -5% | -$204K |
|
1457
Center Bancorp
CNOB
$1.81B
| $3.96M | 0.01% |
209,487
+14,124
| +7% | +$265K |
|
1458
Riley Exploration Permian
REPX
$786M
| $3.94M | 0.01% |
139,000
+67,900
| +95% | +$1.87M |
|
1459
Principal Financial Group
PFG
$24.6B
| $3.92M | 0.01% |
50,000
-89,000
| -64% | -$7.23M |
|
1460
Shell
SHEL
$248B
| $3.91M | 0.01% |
54,200
-31,086
| -36% | -$2.22M |
|
1461
CION Investment
CION
$382M
| $3.91M | 0.01% |
322,600
-229,500
| -42% | -$2.71M |
|
1462
AtriCure
ATRC
$2.21B
| $3.91M | 0.01% |
171,700
+19,500
| +13% | +$450K |
|
1463
Materion
MTRN
$5.88B
| $3.88M | 0.01% |
35,900
+22,300
| +164% | +$2.56M |
|
1464
West Bancorporation
WTBA
$511M
| $3.88M | 0.01% |
216,752
+8,200
| +4% | +$139K |
|
1465
New Jersey Resources
NJR
$5.64B
| $3.88M | 0.01% |
90,700
-19,700
| -18% | -$850K |
|
|
CWAN
1466
DELISTED
Clearwater Analytics
CWAN
| $3.87M | 0.01% |
208,800
-664,300
| -76% | -$12M |
|
|
HBI
1467
DELISTED
Hanesbrands
HBI
| $3.87M | 0.01% |
784,200
-1,354,900
| -63% | -$6.64M |
|
|
OLPX
1468
DELISTED
Olaplex Holdings
OLPX
| $3.85M | 0.01% |
2,501,400
+14,200
| +0.6% | +$22.6K |
|
1469
Sportradar
SRAD
$4.02B
| $3.84M | 0.01% |
343,700
+135,800
| +65% | +$1.41M |
|
1470
iShares ESG Aware MSCI USA ETF
ESGU
$18.5B
| $3.84M | 0.01% |
32,200
+18,500
| +135% | +$2.12M |
|
1471
IDEAYA Biosciences
IDYA
$3.53B
| $3.84M | 0.01% |
+109,325
| New | +$4.33M |
|
1472
James Hardie Industries
JHX
$17.9B
| $3.84M | 0.01% |
121,627
-14,200
| -10% | -$488K |
|
|
MGIC
1473
DELISTED
Magic Software Enterprises
MGIC
| $3.84M | 0.01% |
398,312
-4,752
| -1% | -$53.5K |
|
1474
AnaptysBio
ANAB
$1.66B
| $3.83M | 0.01% |
152,702
+52,502
| +52% | +$1.22M |
|
1475
Spectrum Brands
SPB
$2.09B
| $3.82M | 0.01% |
+44,484
| New | +$3.86M |
|
Similar funds
Jim Simons's Q2 2024 Portfolio in Review
As of Q2 2024, Jim Simons held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $4.49B in Q2 2024, closing 674 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Broadcom worth $472M.
- Jim Simons's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Jim Simons added most to Apple in Q2 2024, an estimated $244M increase.
- Jim Simons's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Jim Simons fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Jim Simons's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Jim Simons opened 463 new positions and closed 674 in Q2 2024.
- Jim Simons's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.